Mcronus Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 27.55%
(FY 2022)
- Profit -12.22%
(FY 2022)
- Ebitda -16.52%
(FY 2022)
- Net Worth 52.54%
(FY 2022)
- Total Assets 19.16%
(FY 2022)
About Mcronus Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Virappa Padsalge, Nirmala Padasalage, Maheshwari Amreshwar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304MH2017PTC301056
- Company No.
301056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mcronus Lifescience?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virappa Padsalge  | Director | 23-Oct-2017 | Current |
| Nirmala Padasalage | Director | 23-Oct-2017 | Current |
| Maheshwari Amreshwar | Director | 23-Oct-2017 | Current |
| Mahesh Padsalge | Director | 23-Oct-2017 | Current |
Financial Performance of Mcronus Lifescience.
Mcronus Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.55% increase. The company also saw a substantial fall in profitability, with a 12.22% decrease in profit. The company's net worth Soared by an impressive increase of 52.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mcronus Lifescience?
In 2022, Mcronus Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Henox Medical Systems Private LimitedActive 3 years 4 monthsMaheshwari Amreshwar and Mahesh Padsalge are mutual person
- Mediworld Laboratories Private LimitedActive 9 years 9 months
Maheshwari Amreshwar and Mahesh Padsalge are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mcronus Lifescience?
Mcronus Lifescience has a workforce of 55 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mcronus Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mcronus Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
